Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
107.87M | 103.28M | 111.44M | 110.47M | 96.03M | 101.54M | Gross Profit |
36.41M | 18.70M | 15.49M | 24.44M | 22.20M | 22.82M | EBIT |
9.22M | 7.18M | 7.96M | 13.63M | 12.42M | 10.79M | EBITDA |
11.92M | 10.38M | 10.66M | 17.07M | 15.39M | 13.57M | Net Income Common Stockholders |
6.39M | 5.18M | 5.87M | 10.18M | 9.47M | 7.82M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.93M | 18.52M | 15.76M | 16.96M | 16.64M | 7.67M | Total Assets |
40.41M | 78.40M | 73.75M | 79.62M | 68.72M | 63.20M | Total Debt |
9.10M | 1.10M | 880.00K | 1.28M | 1.60M | 1.44M | Net Debt |
7.16M | -17.42M | -14.88M | -15.68M | -15.04M | -6.22M | Total Liabilities |
18.22M | 16.94M | 14.94M | 21.87M | 18.13M | 16.11M | Stockholders Equity |
22.16M | 61.45M | 58.81M | 57.33M | 50.26M | 46.86M |
Cash Flow | Free Cash Flow | ||||
5.19M | 6.26M | 4.64M | 4.66M | 12.57M | 3.51M | Operating Cash Flow |
8.00M | 10.73M | 8.52M | 8.01M | 14.52M | 7.80M | Investing Cash Flow |
-2.75M | -4.45M | -4.30M | -3.32M | -1.95M | -4.29M | Financing Cash Flow |
-3.25M | -3.60M | -5.72M | -4.73M | -3.92M | -3.03M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | €75.71M | 11.84 | 10.64% | 3.34% | 7.08% | 58.76% | |
70 Outperform | €6.58B | 22.94 | 14.13% | 1.98% | 6.41% | -5.29% | |
63 Neutral | $4.28B | 11.33 | 5.43% | 214.88% | 4.12% | -8.65% | |
60 Neutral | €9.62B | 20.51 | 10.15% | 3.56% | 0.31% | -11.62% | |
49 Neutral | €153.80M | ― | 3.69% | 4.52% | -41.85% | -143.78% |